featured
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-Analysis
JAMA 2021 Jul 06;[EPub Ahead of Print], M Shankar-Hari, CL Vale, PJ Godolphin, D Fisher, JPT Higgins, F Spiga, J Savovic, J Tierney, G Baron, JS Benbenishty, LR Berry, N Broman, AB Cavalcanti, R Colman, SL De Buyser, LPG Derde, P Domingo, SF Omar, A Fernandez-Cruz, T Feuth, F Garcia, R Garcia-Vicuna, I Gonzalez-Alvaro, AC Gordon, R Haynes, O Hermine, PW Horby, NK Horick, K Kumar, BN Lambrecht, MJ Landray, L Leal, DJ Lederer, E Lorenzi, X Mariette, N Merchante, NA Misnan, SV Mohan, MC Nivens, J Oksi, JA Perez-Molina, R Pizov, R Porcher, S Postma, R Rajasuriar, AV Ramanan, P Ravaud, PD Reid, A Rutgers, A Sancho-Lopez, TB Seto, S Sivapalasingam, AS Soin, N Staplin, JH Stone, GW Strohbehn, J Sunden-Cullberg, J Torre-Cisneros, LW Tsai, H van Hoogstraten, T van Meerten, VC Veiga, PE Westerweel, S Murthy, JV Diaz, JC Marshall, JAC SterneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.